|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Respiratory Division (Drs. Nishimura and Oga), Kyoto-Katsura Hospital, and the Department of Respiratory Medicine (Drs. Izumi and Tsukino), Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Correspondence to: Koichi Nishimura, MD, Respiratory Division, Kyoto-Katsura Hospital, 17 Yamadahirao, Nishikyo-Ku, Kyoto, 615-8256, Japan; e-mail: koichi-nishimura{at}nifty.ne.jp
Background: FEV1 is regarded as the most significant correlate of survival in COPD and is used as a measure of disease severity in the staging of COPD. Recently, however, the categorization of patients with COPD on the basis of the level of dyspnea has similarly been reported to be useful in the prediction of health-related quality of life and improvement in exercise performance after pulmonary rehabilitation.
Study objectives: We compared the effects of the level of dyspnea and disease severity, as evaluated by airway obstruction, on the 5-year survival rate of patients with COPD.
Design and methods: A total of 227 patients with COPD were enrolled in a 5-year, prospective, multicenter study in the Kansai area of Japan, involving 20 divisions of respiratory medicine from various university and city hospitals.
Results: After 5 years, 183 patients were available for the follow-up examination (follow-up rate, 81%). The 5-year cumulative survival rate among patients with COPD was 73%. The effect of disease staging, based on the American Thoracic Society (ATS) guideline as evaluated by the percentage of predicted FEV1, on the 5-year survival rate was not significant (p = 0.08). However, the level of dyspnea was significantly correlated to the 5-year survival rate (p < 0.001). The Cox proportional hazards model revealed that the level of dyspnea had a more significant effect on survival than disease severity based on FEV1.
Conclusions: The categorization of patients with COPD on the basis of the level of dyspnea was more discriminating than staging of disease severity using the ATS guideline with respect to 5-year survival. Dyspnea should be included as one of the variables, in addition to airway obstruction, for evaluating patients with COPD in terms of mortality.
Key Words: airway obstruction categorization COPD dyspnea mortality
This article has been cited by other articles:
![]() |
B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD Chest, December 1, 2007; 132(6): 1778 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Pinto-Plata, R. A. Celli-Cruz, C. Vassaux, L. Torre-Bouscoulet, A. Mendes, J. Rassulo, and B. R. Celli Differences in Cardiopulmonary Exercise Test Results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease Stage Categories and Gender Chest, October 1, 2007; 132(4): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mahler, L. A. Waterman, J. Ward, C. McCusker, R. ZuWallack, and J. C. Baird Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes Chest, October 1, 2007; 132(4): 1283 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Cote, L. J. Dordelly, and B. R. Celli Impact of COPD Exacerbations on Patient-Centered Outcomes Chest, March 1, 2007; 131(3): 696 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. P. Albuquerque, L. E. Nery, D. S. Villaca, T. Y. S. Machado, C. C. Oliveira, A. T. Paes, and J. A. Neder Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Eur. Respir. J., November 1, 2006; 28(5): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Esteban, J.M. Quintana, M. Aburto, J. Moraza, and A. Capelastegui A simple score for assessing stable chronic obstructive pulmonary disease QJM, November 1, 2006; 99(11): 751 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Celli Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mahler Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2006; 3(3): 234 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. Calverley Dynamic Hyperinflation: Is It Worth Measuring? Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. de Torres, E. Cordoba-Lanus, C. Lopez-Aguilar, M. Muros de Fuentes, A. Montejo de Garcini, A. Aguirre-Jaime, B. R. Celli, and C. Casanova C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Eur. Respir. J., May 1, 2006; 27(5): 902 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Mannino, M. M. Reichert, and K. J. Davis Lung Function Decline and Outcomes in an Adult Population Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 985 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Celli Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery. Chest, April 1, 2006; 129(4): 835 - 836. [Full Text] [PDF] |
||||
![]() |
S. Imfeld, K. E. Bloch, W. Weder, and E. W. Russi The BODE Index After Lung Volume Reduction Surgery Correlates With Survival. Chest, April 1, 2006; 129(4): 873 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell Is Sustained Pharmacologic Lung Volume Reduction Now Possible in COPD? Chest, March 1, 2006; 129(3): 501 - 503. [Full Text] [PDF] |
||||
![]() |
J J Soler-Cataluna, M A Martinez-Garcia, P Roman Sanchez, E Salcedo, M Navarro, and R Ochando Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax, November 1, 2005; 60(11): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Cote and B. R. Celli Pulmonary rehabilitation and the BODE index in COPD Eur. Respir. J., October 1, 2005; 26(4): 630 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
N F Schlecht, K Schwartzman, and J Bourbeau Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease Chronic Respiratory Disease, October 1, 2005; 2(4): 183 - 191. [Abstract] [PDF] |
||||
![]() |
C. Casanova, C. Cote, J. P. de Torres, A. Aguirre-Jaime, J. M. Marin, V. Pinto-Plata, and B. R. Celli Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Nathan Lung Transplantation: Disease-Specific Considerations for Referral Chest, March 1, 2005; 127(3): 1006 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Golish The BODE index predicted death in chronic obstructive pulmonary disease Evid. Based Med., September 1, 2004; 9(5): 156 - 156. [Full Text] [PDF] |
||||
![]() |
B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J., June 1, 2004; 23(6): 932 - 946. [Full Text] [PDF] |
||||
![]() |
B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Parekh, J. A. Blumenthal, M. A. Babyak, K. Merrill, R. M. Carney, R. D. Davis, and S. M. Palmer Psychiatric Disorder and Quality of Life in Patients Awaiting Lung Transplantation Chest, November 1, 2003; 124(5): 1682 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |